Adeno-Associated Virus (Aav) Serotype 8 Sequences, Vectors Containing Same And Uses Therefor - EP3517134

The patent EP3517134 was granted to The Trustees OF The University OF Pennsylvania on Jan 17, 2024. The application was originally filed on Nov 12, 2002 under application number EP18212719A. The patent is currently recorded with a legal status of "Revoked".

EP3517134

THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA
Application Number
EP18212719A
Filing Date
Nov 12, 2002
Status
Revoked
Mar 21, 2025
Grant Date
Jan 17, 2024
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

STRAWMANOct 16, 2024VOSSIUS & PARTNER PATENTANWALTE RECHTSANWALTE MBBADMISSIBLE

Patent Citations (12) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
DESCRIPTIONWO1998US19463
DESCRIPTIONUS5478745
DESCRIPTIONUS5658785
DESCRIPTIONWO9810088
OPPOSITIONEP3517134
OPPOSITIONUS6156303
OPPOSITIONWO0028061
OPPOSITIONWO03052051
OPPOSITIONWO9811244
OPPOSITIONWO9961601
SEARCHEP1310571
SEARCHUS6156303

Non-Patent Literature (NPL) Citations (81) New

NPL citations refer to non-patent references such as research papers, articles, or other publications cited during examination or opposition phases.

Citation PhaseReference Text
DESCRIPTION- ANDERSEN et al., Cell. Mol. Neurobiol., (19930000), vol. 13, pages 503 - 15
DESCRIPTION- ARBUTHNOT et al., Hum. Gene Ther., (19960000), vol. 7, pages 1503 - 14
DESCRIPTION- AXELROD et al., Proc.Natl.Acad.Sci. USA, (19900000), vol. 87, pages 5173 - 5177
DESCRIPTION- BOSHART et al., Cell, (19850000), vol. 41, pages 521 - 530
DESCRIPTION- CHEN, J. Bone Miner. Res., (19960000), vol. 11, pages 654 - 64
DESCRIPTION- CHEN SJ et al., Mol Therapy, (20000000), vol. 2, no. 3, pages 256 - 261
DESCRIPTION- CHIORINI et al., J. Virol, (19990000), vol. 73, pages 1309 - 19
DESCRIPTION- CHIRMULE, N. et al., Gene Ther, (19990000), vol. 6, pages 1574 - 83
DESCRIPTION- EVANS et al., Proc. Natl. Acad. Sci. USA, (19890000), vol. 86, pages 10095 - 10099
DESCRIPTION- FISHER et al., Nature Med., (19970300), vol. 3, no. 3, pages 306 - 312
DESCRIPTION- FRIEZNER-DEGEN et al., J. Biol. Chem., (19860000), vol. 261, pages 6972 - 6985
DESCRIPTION- FURLER, S. et al., Gene Ther., (20010600), vol. 8, no. 11, pages 864 - 873
DESCRIPTION- GAO, G. et al., Hum Gene Ther, (20000000), vol. 11, pages 2079 - 91
DESCRIPTION- GAO GP et al., Hum Gene Ther., (20001010), vol. 11, no. 15, pages 2079 - 91
DESCRIPTION- GAO, G. P. et al., J Virol, (19960000), vol. 70, pages 8934 - 43
DESCRIPTION- GOSSEN et al., Proc. Natl. Acad. Sci. USA, (19920000), vol. 89, pages 5547 - 5551
DESCRIPTION- GOSSEN et al., Science, (19950000), vol. 268, pages 1766 - 1769
DESCRIPTION- HANSAL et al., J. ImmunoI., (19980000), vol. 161, pages 1063 - 8
DESCRIPTION- HARVEY et al., Curr. Opin. Chem. Biol., (19980000), vol. 2, pages 512 - 518
DESCRIPTION- HILDINGER M et al., J. Virol, (20010000), vol. 75, pages 6199 - 6203
DESCRIPTION- K. FISHER et al., J. Virol., (19930000), vol. 70, pages 520 - 532
DESCRIPTION- KLUMP H. et al., Gene Ther., (20010500), vol. 8, no. 10, pages 811 - 817
DESCRIPTION- LI et al., Nat. Biotech., (19990000), vol. 17, pages 241 - 245
DESCRIPTION- MAGARI, 1. Clin. Invest., (19970000), vol. 100, pages 2865 - 2872
DESCRIPTION- MERRIFIELD, J. Am. Chem. Soc., (19620000), vol. 85, page 2149
DESCRIPTION- MIYATAKE et al., J. Virol., (19970000), vol. 71, pages 5124 - 32
DESCRIPTION- M.L. DONNELLY et al., J. Gen. Virol., (19970100), vol. 78, pages 13 - 21
DESCRIPTION- NO et al., Proc. Natl. Acad. Sci. USA, (19960000), vol. 93, pages 3346 - 3351
DESCRIPTION- PICCIOLI et al., Neuron, (19950000), vol. 15, pages 373 - 84
DESCRIPTION- PICCIOLI et al., Proc. Natl. Acad. Sci. USA, (19910000), vol. 88, pages 5611 - 5
DESCRIPTION- RUTLEDGE et al., J. Virol., vol. 72, pages 309 - 319
DESCRIPTION- SAMBROOK et al., Molecular Cloning: A Laboratory Manual, Cold Spring Harbor Press
DESCRIPTION- SANDIG et al., Gene Ther., (19960000), vol. 3, pages 1002 - 9
DESCRIPTION- SIEBERT, Nucleic Acid Research, (19950000), vol. 23, pages 1087 - 1088
DESCRIPTION- STEIN et al., Mol. Biol. Rep., (19970000), vol. 24, pages 185 - 96
DESCRIPTION- STEWART; YOUNG, Solid Phase Peptide Synthesis, (19690000), pages 27 - 62
DESCRIPTION- WANG et al., Froc. Natl. Acad. Sci. USA, (19970000), vol. 94, pages 11563 - 11566
DESCRIPTION- WANG et al., Gene Ther., (19970000), vol. 4, pages 432 - 441
DESCRIPTION- WANG et al., Molecular Therapy, (20000000), vol. 2, pages 154 - 158
DESCRIPTION- WANG et al., Nat. Biotech., (19970000), vol. 15, pages 239 - 243
DESCRIPTION- WANG et al., Proc. Natl. Acad. Sci. USA, (19970000), vol. 94, pages 11563 - 11566
DESCRIPTION- WANG, L. et al., Proc Natl Acad Sci USA, (19970000), vol. 94, pages 11563 - 6
DESCRIPTION- WANG, L. et al., Proc Natl Acad Sci USA, vol. 94, pages 11563 - 6
DESCRIPTION- W. C. MANNING et al., Human Gene Therapy, (19980301), vol. 9, pages 477 - 485
DESCRIPTION- XIAO et al., J. Virol, (19990000), vol. 73, pages 3994 - 4003
DESCRIPTION- XIAO, W. et al., J Virol, (19990000), vol. 73, pages 3994 - 4003
DESCRIPTION- X. YE et al., J, Biol. Chem., (19960200), vol. 271, no. 7, pages 3639 - 3646
DESCRIPTION- X. YE et al., Pediatric Research, (19970000), vol. 41, no. 4, pages 527 - 534
DESCRIPTION- ZHANG, Y. et al., Mol Ther, (20010000), vol. 3, pages 697 - 707
DESCRIPTION- ZOLTICK, P. W.; WILSON, J. M., Mol Ther, (20000000), vol. 2, pages 657 - 9
OPPOSITION- Anonymous, "Adeno-associated virus 7 nonstructural protein and capsid protein gene", Nucleotide , (20020905), Database accession no. AF513851, XP093233032
OPPOSITION- Anonymous, "Adeno-associated virus 8 nonstructural protein and capsid protein gene complete cds", genbank, (20020905), Database accession no. AF513852, XP055393951
OPPOSITION- D14a - MOLECULAR THERAPY - INFORMATION FOR AUTHORS
OPPOSITION- D19 - Auxiliary Request 1 presented by Patentee during the oral proceedings of the parental case EP 1 453 547 on October 10, 2018 (“AR1_p”)
OPPOSITION- D20 - GROUNDS FOR DECISION DATED NOVEMBER 30, 2018 IN THE PARENTAL CASE EP 1 453 547
OPPOSITION- D30 - MARKED-UP VERSION OF THE ADAPTED DESCRIPTION FILED WITH PATENTEE'S SUBMISSION OF JUNE 17, 2022
OPPOSITION- GAO G.-P., YANG Y., WILSON J. M., "BIOLOGY OF ADENOVIRUS VECTORS WITH E1 AND E4 DELETIONS FOR LIVER-DIRECTED GENE THERAPY.", Journal of Virology, THE AMERICAN SOCIETY FOR MICROBIOLOGY, US, US , (19961201), vol. 70., no. 12., ISSN 0022-538X, pages 8934 - 8943., XP000939184
OPPOSITION- RUTLEDGE E. A., HALBERT C. L., RUSSELL D. W., "INFECTIOUS CLONES AND VECTORS DERIVED FROM ADENO-ASSOCIATED VIRUS (AAV) SEROTYPES OTHER THAN AAV TYPE 2.", Journal of Virology, THE AMERICAN SOCIETY FOR MICROBIOLOGY, US, US , (19980101), vol. 72., ISSN 0022-538X, pages 309 - 319., XP002924102
OPPOSITION- Jun Mimuro, Hiroaki Mizukami, Midori Shima, Tadashi Matsushita, Masashi Taki, Shinji Muto, Satoshi Higasa, Michio Sakai, Tsukasa Ohmori, Seiji Madoiwa, Keiya Ozawa, Yoichi Sakata, "The prevalence of neutralizing antibodies against adeno-associated virus capsids is reduced in young Japanese individuals : Prevalence of Antibodies Against AAV", JOURNAL OF MEDICAL VIROLOGY, John Wiley & Sons, Inc., US, US , (20141101), vol. 86, no. 11, doi:10.1002/jmv.23818, ISSN 0146-6615, pages 1990 - 1997, XP055634233
OPPOSITION- Michael A. Schnell, Et Al, "Activation of Innate Immunity in Nonhuman Primates Following Intraportal Administration of Adenoviral Vectors", Molecular Therapy, Elsevier Inc., US, US , (20010501), vol. 3, no. 5, doi:10.1006/mthe.2001.0330, ISSN 1525-0016, pages 708 - 722, XP055393958
OPPOSITION- K E Brown, S W Green, M G O'Sullivan, N S Young, "Cloning and sequencing of the simial parvovirus genome", Virology, ELSEVIER, AMSTERDAM, NL, AMSTERDAM, NL , (19950710), vol. 210, no. 2, doi:10.1006/viro.1995.1348, ISSN 0042-6822, pages 314 - 322, XP055393961
OPPOSITION- Green, S.W. Malkovska, I. O'Sullivan, M.G. Brown, K.E., "Rhesus and Pig-Tailed Macaque Parvoviruses: Identification of Two New Members of the Erythrovirus Genus in Monkeys", Virology, ELSEVIER, AMSTERDAM, NL, AMSTERDAM, NL , (20000330), vol. 269, no. 1, doi:10.1006/viro.2000.0215, ISSN 0042-6822, pages 105 - 112, XP004436331
OPPOSITION- Durigon, E.L. ; Erdman, D.D. ; Gary, G.W. ; Pallansch, M.A. ; Torok, T.J. ; J.Anderson, L., "Multiple primer pairs for polymerase chain reaction (PCR) amplification of human parvovirus B19 DNA", Journal of virological methods, Elsevier BV, NL, NL , (19931001), vol. 44, no. 2-3, doi:10.1016/0166-0934(93)90051-R, ISSN 0166-0934, pages 155 - 165, XP023696916
OPPOSITION- Z Zádori, J Szelei, M C Lacoste, Y Li, S Gariépy, P Raymond, M Allaire, I R Nabi, P Tijssen, "A Viral Phospholipase A 2 Is Required for Parvovirus Infectivity Parvoviruses package a single-stranded DNA into a", Developmental Cell, Cell Press, US, US , (20010801), vol. 1, no. 2, doi:10.1016/s1534-5807(01)00031-4, ISSN 1534-5807, pages 291 - 302, XP055393964
OPPOSITION- Liu Q; Huang W; Zhang H; Wang Y; Zhao J; Song A; Xie H; Zhao C; Gao D; Wang Y, "Neutralizing antibodies against AAV2, AAV5 and AAV8 in healthy and HIV-1-infected subjects in China: implications for gene therapy using AAV vectors", Gene Therapy, Nature Publishing Group, London, GB, GB , (20140522), vol. 21, no. 8, doi:10.1038/gt.2014.47, ISSN 0969-7128, pages 732 - 738, XP037772179
OPPOSITION- Koen Vercauteren, Brad E Hoffman, Irene Zolotukhin, Geoffrey D Keeler, Jing W Xiao, Etiena Basner-Tschakarjan, Katherine A High, Hildegund Cj Ertl, Charles M Rice, Arun Srivastava, Ype P De Jong, Roland W Herzog, "Superior In vivo Transduction of Human Hepatocytes Using Engineered AAV3 Capsid", Molecular Therapy, Elsevier Inc., US, US , (20160601), vol. 24, no. 6, doi:10.1038/mt.2016.61, ISSN 1525-0016, pages 1042 - 1049, XP055634254
OPPOSITION- Chao H; Samulski R J; Bellinger D A; Monahan P E; Nichols T C; Walsh C E, "Persistent expression of canine factor IX in hemophilia B canines", Gene Therapy, Nature Publishing Group, London, GB, GB , (19991001), vol. 6, no. 10, doi:10.1038/sj.gt.3301024, ISSN 0969-7128, pages 1695 - 1704, XP037771988
OPPOSITION- Guang-Ping Gao et al., "Novel adeno-associated viruses from rhesus monkeys as vectors for human gene therapy", PNAS, (20020903), vol. 99, page 18, XP002589975
OPPOSITION- WEITZMAN M. D., ET AL., "ADENO-ASSOCIATED VIRUS (AAV) REP PROTEINS MEDIATE COMPLEX FORMATION BETWEEN AAV DNA AND ITS INTEGRATION SITE IN HUMAN DNA.", Proceedings of the National Academy of Sciences (PNAS), National Academy of Sciences, (19940601), vol. 91., doi:10.1073/pnas.91.13.5808, ISSN 0027-8424, pages 5808 - 5812., XP002912505
OPPOSITION- KOEBERL D D,ET AL, "Persistent expression of human clotting factor IX from mouse liver after intravenous injection of adeno-associated virus vectors", Proceedings of the National Academy of Sciences (PNAS), National Academy of Sciences, (19970201), vol. 94, no. 4, doi:10.1073/pnas.94.4.1426, ISSN 0027-8424, pages 1426 - 1431, XP002287408
OPPOSITION- Anne Girod, Christiane E Wobus, Zoltán Zádori, Martin Ried, Kristin Leike, Peter Tijssen, Jürgen A Kleinschmidt, Michael Hallek, "The VP1 capsid protein of adeno-associated virus type 2 is carrying a phospholipase A2 domain required for virus infectivity.", Journal of General Virology, Society for General Microbiology, (20020501), vol. 83, no. Pt 5, doi:10.1099/0022-1317-83-5-973 , ISSN 0022-1317, pages 973 - 978, XP002369265
OPPOSITION- Parks Wade P., Boucher D. Wark, Melnick Joseph L., Taber Larry H., Yow Martha D., "Seroepidemiological and Ecological Studies of the Adenovirus-Associated Satellite Viruses", Infection and immunity, American Society for Microbiology, US, US , (19701201), vol. 2, no. 6, doi:10.1128/iai.2.6.716-722.1970, ISSN 0019-9567, pages 716 - 722, XP093233022
OPPOSITION- Grieger Joshua C., Johnson Jarrod S., Gurda-Whitaker Brittney, Agbandje-Mckenna Mavis, Samulski R. Jude, "Surface-Exposed Adeno-Associated Virus Vp1-NLS Capsid Fusion Protein Rescues Infectivity of Noninfectious Wild-Type Vp2/Vp3 and Vp3-Only Capsids but Not That of Fivefold Pore Mutant Virions", Journal of Virology, THE AMERICAN SOCIETY FOR MICROBIOLOGY, US, US , (20070801), vol. 81, no. 15, doi:10.1128/JVI.00580-07, ISSN 0022-538X, pages 7833 - 7843, XP055872375
OPPOSITION- Afione S A; Conrad C K; Kearns W G; Chunduru S; Adams R; Reynolds T C; Guggino W B; Cutting G R; Carter B J; Flotte T R, "IN VIVO MODEL OF ADENO-ASSOCIATED VIRUS VECTOR PERSISTENCE AND RESCUE", Journal of Virology, THE AMERICAN SOCIETY FOR MICROBIOLOGY, US, US , (19960501), vol. 70, no. 05, doi:10.1128/jvi.70.5.3235-3241.1996, ISSN 0022-538X, pages 3235 - 3241, XP000828293
OPPOSITION- Y J Hernandez, J Wang, W G Kearns, S Loiler, A Poirier, T R Flotte, "Latent Adeno- associated virus infection elicits humoral but not cell -mediated immune responses in a nonhuman primate model", Journal of Virology, THE AMERICAN SOCIETY FOR MICROBIOLOGY, US, US , (19991001), vol. 73, no. 10, doi:10.1128/JVI.73.10.8549-8558.1999, ISSN 0022-538X, pages 8549 - 8558, XP055393957
OPPOSITION- XIAO W. ET AL., "Gene therapy vectors based on adeno-associated virus type 1.", Journal of Virology, THE AMERICAN SOCIETY FOR MICROBIOLOGY, US, US , (19990501), vol. 73, no. 5, doi:10.1128/JVI.73.5.3994-4003.1999, ISSN 0022-538X, pages 3994 - 4003, XP002137090
SEARCH- "Adeno-associated virus 8 nonstructural protein and capsid protein genes, complete cds.", EMBL, (20020904), Database accession no. AF513852, URL: EBI, XP002790233 [P] * sequence . *
SEARCH- RUTLEDGE E A ET AL, "Infectious clones and vectors derived from adeno-associated virus (AAV) serotypes other than AAV type 2", JOURNAL OF VIROLOGY, THE AMERICAN SOCIETY FOR MICROBIOLOGY, US, (199801), vol. 72, no. 1, ISSN 0022-538X, pages 309 - 319, XP002137089 [XD] 1-4,6,7,10-12,14-19 * see the whole document, in particular the section "Vectors based on AAV3B and AAV6" *
SEARCH- XIAO WEIDONG ET AL, "Gene therapy vectors based on adeno-associated virus type 1", JOURNAL OF VIROLOGY, THE AMERICAN SOCIETY FOR MICROBIOLOGY, US, (19990501), vol. 73, no. 5, ISSN 0022-538X, pages 3994 - 4003, XP002229851 [X] 1-4,6,7,10-12,14-20,29 * see the whole document, in particular the section "Recombinant vector based on AAV-1";; figure 5 *
SEARCH- GAO G-P ET AL, "Novel adeno-associated viruses from rhesus monkeys as vectors for human gene therapy", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, NATIONAL ACADEMY OF SCIENCES, US, (20020903), vol. 99, no. 18, doi:10.1073/PNAS.182412299, ISSN 0027-8424, pages 11854 - 11859, XP002229849 [XP] 1-12,14-20,22,23,29 * the whole document *
SEARCH- CHIRMULE N ET AL, "Humoral immunity to adeno-associated virus type 2 vectors following administration to murine and nonhuman primate muscle", JOURNAL OF VIROLOGY, THE AMERICAN SOCIETY FOR MICROBIOLOGY, US, (20000301), vol. 74, no. 5, doi:10.1128/JVI.74.5.2420-2425.2000, ISSN 0022-538X, pages 2420 - 2425, XP002971425 [X] 1-4,6,7,10-12,14-20,29 * the whole document *

Download Citation Report

Get a free citation report including examiner, opposition, and international search citations.

Get Citation Report

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents